Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-859X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study ; volume:20 ; number:1 ; day:24 ; month:4 ; year:2021 ; pages:1-7 ; date:12.2021
Annals of general psychiatry ; 20, Heft 1 (24.4.2021), 1-7, 12.2021
- Creator
-
Bahta, Merhawi
Ogbaghebriel, Azieb
Russom, Mulugeta
Tesfamariam, Eyasu H.
Berhe, Tzeggai
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12991-021-00348-0
- URN
-
urn:nbn:de:101:1-2021061320172885930871
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bahta, Merhawi
- Ogbaghebriel, Azieb
- Russom, Mulugeta
- Tesfamariam, Eyasu H.
- Berhe, Tzeggai
- SpringerLink (Online service)
Other Objects (12)
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia